Use of Enterally Delivered Angiotensin II Type Ia Receptor Antagonists to Reduce the Severity of Colitis

Blockage of angiotensin II type 1 receptor regulates TNF-α-induced MAdCAM-1 expression via inhibition of NF-κB translocation to the nucleus and ameliorates colitis

(2009) Takashi Mizushima et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Modulation of mouse intestinal epithelial cell turnover in the absence of angiotensin converting enzyme

(2008) Emir Q. Haxhija et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation

(2008) Micheline M. de Resende et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

The role of angiotensin II type 1a receptor on intestinal epithelial cells following small bowel resection in a mouse model

(2008) Hiroyuki Koga et al.   PEDIATRIC SURGERY INTERNATIONAL

Transanal delivery of angiotensin converting enzyme inhibitor prevents colonic fibrosis in a mouse colitis model: development of a unique mode of treatment

(2008) Hiroyuki Koga et al.   SURGERY

Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis

(2008) Marcia L Moss et al.   Nature clinical practice. Rheumatology

An angiotensin II receptor antagonist reduces inflammatory parameters in two models of colitis

(2007) Olga I. Santiago et al.   REGULATORY PEPTIDES